Ibuprofen treats many of your common pains, from a headache to sore feet. You can even reach for ibuprofen if you have a ...

Ibuprofen is available in different strengths, including 200 mg, 400 mg, 600 mg, and 800 mg capsules, suspensions, and ...

A test tube labelled "Bird Flu", eggs and a piece of paper in the colors of the U.S. national flag are seen in this picture illustration, January 14, 2023. REUTERS/Dado Ruvic/Illustration/File ...

Now showing summary data for the 2024 election cycle. Now showing data for the election cycle. The pharmaceutical and health products industry — including not only drug manufacturers but also dealers ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

[6] Here we report the findings of two studies on the pharmacokinetic properties of a novel ibuprofen (200 mg) and paracetamol (500 mg) fixed-dose combination tablet. These studies were conducted ...

The 21st century pharmaceutical and biotech sector has ... and even drugs as ubiquitous as paracetamol and ibuprofen were developed in 1956 and 1969 respectively. As the 1970s drew to an end ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected to ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the ...

WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics ...

SAN DIEGO, October 17, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesday, November 6, 2024, after the close of the U ...